Solution Group

Solution Group Berhad is a Malaysian investment holding company that has strategically pivoted into the biotechnology and healthcare sectors, primarily through its subsidiary Solution Biologics (SOLBIO). The company is a prominent regional partner for CanSino Biologics, providing fill-and-finish manufacturing and distribution services for the Convidecia COVID-19 vaccine across Southeast Asia. Beyond its pandemic response, Solution Group is building a diversified vaccine pipeline through collaborations with the National Institutes of Biotechnology Malaysia (NIBM) and international biotech firms like Xiamen Innovax Biotech. Its portfolio includes programs for HPV, meningitis, dengue, and Zika, supported by specialized manufacturing infrastructure in Technology Park Malaysia. The company is publicly traded on the Bursa Malaysia and plays a central role in the region's growing biopharmaceutical ecosystem.